Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy

F. Bombelli; F. Lagona; A. Salvati; L. Catalfamo; A. G. Ferrari; C. Pappone

doi:10.1016/S0029-7844(03)00119-4

Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy

F. Bombelli, F. Lagona, A. Salvati, L. Catalfamo, A. G. Ferrari, C. Pappone

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article › peer-review

Abstract

BACKGROUND: Treatment of maternal tachyarrhythmias in pregnancy is a major clinical issue. Pharmacological treatment raises important concerns regarding partial efficacy and side effects. Radiofrequency ablation of arrhythmogenic substrate has rarely been performed during pregnancy because of the fetal risks related to x-ray exposure and potential fetomaternal procedural complications. CASES: Three women affected by supraventricular tachycardias refractory to pharmacological therapy underwent successful radiofrequency catheter ablation at 29 to 30 weeks' pregnancy. All patients had cesarean delivery of newborns with normal Apgar scores. CONCLUSION: Radiofrequency catheter ablation is an effective treatment of drug refractory maternal supraventricular tachycardias in advanced pregnancy. Further studies are required to establish its long-term fetal safety.

Original language	English
Pages (from-to)	1171-1173
Number of pages	3
Journal	Obstetrics and Gynecology
Volume	102
Issue number	5 SUPPL.
DOIs	https://doi.org/10.1016/S0029-7844(03)00119-4
Publication status	Published - Nov 2003

ASJC Scopus subject areas

Obstetrics and Gynaecology

Access to Document

10.1016/S0029-7844(03)00119-4

Cite this

@article{9703a48c5131417ab1513a7cdadb5b4d,

title = "Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy",

abstract = "BACKGROUND: Treatment of maternal tachyarrhythmias in pregnancy is a major clinical issue. Pharmacological treatment raises important concerns regarding partial efficacy and side effects. Radiofrequency ablation of arrhythmogenic substrate has rarely been performed during pregnancy because of the fetal risks related to x-ray exposure and potential fetomaternal procedural complications. CASES: Three women affected by supraventricular tachycardias refractory to pharmacological therapy underwent successful radiofrequency catheter ablation at 29 to 30 weeks' pregnancy. All patients had cesarean delivery of newborns with normal Apgar scores. CONCLUSION: Radiofrequency catheter ablation is an effective treatment of drug refractory maternal supraventricular tachycardias in advanced pregnancy. Further studies are required to establish its long-term fetal safety.",

author = "F. Bombelli and F. Lagona and A. Salvati and L. Catalfamo and Ferrari, {A. G.} and C. Pappone",

year = "2003",

month = nov,

doi = "10.1016/S0029-7844(03)00119-4",

language = "English",

volume = "102",

pages = "1171--1173",

journal = "Obstetrics and Gynecology",

issn = "0029-7844",

publisher = "Lippincott Williams and Wilkins",

number = "5 SUPPL.",

}

TY - JOUR

T1 - Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy

AU - Bombelli, F.

AU - Lagona, F.

AU - Salvati, A.

AU - Catalfamo, L.

AU - Ferrari, A. G.

AU - Pappone, C.

PY - 2003/11

Y1 - 2003/11

N2 - BACKGROUND: Treatment of maternal tachyarrhythmias in pregnancy is a major clinical issue. Pharmacological treatment raises important concerns regarding partial efficacy and side effects. Radiofrequency ablation of arrhythmogenic substrate has rarely been performed during pregnancy because of the fetal risks related to x-ray exposure and potential fetomaternal procedural complications. CASES: Three women affected by supraventricular tachycardias refractory to pharmacological therapy underwent successful radiofrequency catheter ablation at 29 to 30 weeks' pregnancy. All patients had cesarean delivery of newborns with normal Apgar scores. CONCLUSION: Radiofrequency catheter ablation is an effective treatment of drug refractory maternal supraventricular tachycardias in advanced pregnancy. Further studies are required to establish its long-term fetal safety.

AB - BACKGROUND: Treatment of maternal tachyarrhythmias in pregnancy is a major clinical issue. Pharmacological treatment raises important concerns regarding partial efficacy and side effects. Radiofrequency ablation of arrhythmogenic substrate has rarely been performed during pregnancy because of the fetal risks related to x-ray exposure and potential fetomaternal procedural complications. CASES: Three women affected by supraventricular tachycardias refractory to pharmacological therapy underwent successful radiofrequency catheter ablation at 29 to 30 weeks' pregnancy. All patients had cesarean delivery of newborns with normal Apgar scores. CONCLUSION: Radiofrequency catheter ablation is an effective treatment of drug refractory maternal supraventricular tachycardias in advanced pregnancy. Further studies are required to establish its long-term fetal safety.

UR - http://www.scopus.com/inward/record.url?scp=0242352614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242352614&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(03)00119-4

DO - 10.1016/S0029-7844(03)00119-4

M3 - Article

C2 - 14607046

AN - SCOPUS:0242352614

SN - 0029-7844

VL - 102

SP - 1171

EP - 1173

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

IS - 5 SUPPL.

ER -

Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this